Biovica presents at the Annual Biomarkers Congress in Manchester 2018
Uppsala, Sweden, November 8, 2017. Mattias Bergqvist, VP Clinical Development at Biovica is invited to talk at the 13th Annual Biomarkers Congress 15-16 February 2018, Manchester, UK. As part of the congress Mattias will present at a free webinar on November 28, 2017.
At the conference Mattias will address how novel ways to measure cell proliferation offers new solutions to old challenges in drug development. Enhanced evaluation of drug efficacy by new assays such as DiviTum® can save development time and cost and provide key information during preclinical and clinical trials, with the aim to bring new drugs to the market faster.
The Biomarker Congress includes presentations, case studies, novel technologies and panel discussions focused on the opportunities and challenges of biomarker development.
Biovica International is a company focused on providing liquid biomarkers for measuring cell proliferation and efficacy evaluation of novel cancer drugs. Mattias Bergqvist has global responsibility for clinical strategy and developing the clinical study program in collaboration with Biovica’s partners in the US & EU. During his more than 20 years of experience in the pharmaceutical and biotechnology industry, he has been Therapeutic Area Director, Oncology at AstraZeneca Nordics and worked in the Global Oncology Department, AstraZeneca UK. His areas of expertise include clinical study and market strategy during drug and biomarker development.
For more information:
Cecilia Driving, CFO Biovica
Tel.: +46 (0)73 125 92 47
Numbers of patients in studies
Search the site
Search on Biovica
Are you a US resident?
Only US residents will be able to qualify for this program
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
This cookie is installed by Google Analytics.
A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Hotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
Hotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
Hotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
Hotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.